Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004989691 | SCV005603958 | uncertain significance | Inborn genetic diseases | 2024-08-27 | criteria provided, single submitter | clinical testing | The c.1462C>G (p.P488A) alteration is located in exon 4 (coding exon 3) of the KANSL1 gene. This alteration results from a C to G substitution at nucleotide position 1462, causing the proline (P) at amino acid position 488 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV005110393 | SCV005762133 | uncertain significance | Koolen-de Vries syndrome | 2024-07-30 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 488 of the KANSL1 protein (p.Pro488Ala). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with KANSL1-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt KANSL1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |